Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celgosivir monotherapy in chronic hepatitis C
NCT00157534Phase 2Completed
- Sponsor
- BioWest Therapeutics
- Start
- Oct 2004
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of celgosivir in hepatitis C (HCV) (2 arms), sponsored by BioWest Therapeutics. Primary endpoint: Safety analysis. Started Oct 2004; status: completed.
02
Drugs
celgosivir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00157534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157534.